Ledger.Open graph →
SEC Form D · filed October 2, 2024

Aktis Oncology, Inc

Offering
$175.0M
Sold
$175.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

A. Rich · Boston, MAExec · DirectorHelen S. Kim · Boston, MADirectorShulamit S. Ron-Bigger · Boston, MAExecKen S. Herrmann · Boston, MADirectorLloyd S. Segal · Boston, MADirectorOleg Nodelman · Boston, MADirectorAndrew S. Levin · Boston, MADirectorMatthew Roden · Boston, MAExec · DirectorTodd Foley · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗